Best Practices Developed for Use of EHR to Enhance Patient Care
Patients regard EHR as positive presence; can be used to engage patients by jointly viewing data
Report finds 47.2 million doses lost due to health care worker misuse and theft in 2018
RAND researchers recommend private insurers move toward fixed - price arrangements
Statement by Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, and Maureen M. Goodenow, Ph.D., NIH Associate Director for AIDS Research and Director, Office of AIDS Research
While coexistence of neuromeningeal cryptococcosis and Kaposi's sarcoma is not unusual in HIV infection with a low CD4 count, this case demonstrates that it can occur even with a high CD4 count.Journal of Medical Case Reports
For the past few months, NIGMS has been reviewing its HIV/AIDS grant portfolio. As the HIV/AIDS field has matured and the necessary research directions have become clearer, the HIV/AIDS-related grants we’ve supported have, appropriately, become more narrowly focused. Because of this, and after close consultation with leadership at the National Institute of Allergy and Infectious Diseases (NIAID), we’ve concluded that it’s in the best interest of the research to transition NIGMS’ HIV/AIDS portfolio to NIAID to allow improved scientific coordination, prioritization, and efficiency of management. ...
How might improvements along the HIV continuum, especially scaling up HIV preexposure prophylaxis, reduce racial disparities in HIV incidence?American Journal of Epidemiology
We describe a 57-year-old male with human immunodeficiency virus who presented to us with chronic diarrhea. He had no history of allergies and had significant weight loss, normal systemic examination, and a complete blood count showing no eosinophilia. After an esophagogastroduodenoscopy, the diagnosis of EGE was made by histopathological findings. The symptoms started improving with the initiation of treatment with oral prednisolone.
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
67 trials ID'd that were unreported for median of nine years after completion, with 87,883 participants
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs